0.000
0.00 (0.00%)
AISkor Stockmoo
| Nilai 60% | -5.0 |
| Keuntungan lemah. Kecairan jangka pendek nipis. Aliran tunai negatif. info | |
| Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info | NA |
| Penilaian Relatif info | NA |
| Pertumbuhan Tersirat info | NA |
| Sejarah Penilaian info | NA |
| Pulangan atas Modal info | NA |
| Trend Perolehan info | NA |
| Nilai Pegangan info | NA |
| Premium Risiko info | NA |
| Penilaian Pasaran info | NA |
| Masa | NA |
| Daripada analisis teknikal AI kami terhadap carta. info | NA |
| Kekuatan Aliran info | NA |
| Persediaan Teknikal info | NA |
| Corak Lilin info | NA |
| Aliran Jangka Sederhana info | NA |
| Sentimen 40% | 0.0 |
| Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info | |
| Sentimen Pegangan info | NA |
| Sentimen Berita info | NA |
| Wang Pintar | NA |
| Aktiviti Orang Dalam info | NA |
| Aliran Institusi info | NA |
| Kedudukan Jual Singkat info | NA |
| Keadaan pasaran dan sektor menggalakkan. | |
| Persekitaran pasaran berhati-hati. info | |
| Sektor mengatasi prestasi pasaran. | |
| Hanya satu tonggak mempunyai bacaan yang jelas, jadi skor tidak berubah. | |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | NA |
| Tiada aliran jelas bagi jangka pendek, sederhana dan panjang. info | |
| Tiada isyarat jelas daripada sokongan dan rintangan. info | |
| Skor Akhir | -2.88 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | LumiraDx Limited | - | - |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B | Skor |
|---|---|---|---|---|---|
| LMDWF | - | - | - | - | -2.9 |
| BNR | 140 M | - | - | 1.84 | -0.7 |
| ADVB | - | - | - | 0.280 | -2.3 |
| GH | 20 B | - | - | - | -0.6 |
| MEDP | 18 B | - | 35.20 | 31.23 | 1.2 |
| IDXX | - | - | - | 29.54 | 0.0 |
|
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company is headquartered in London, the United Kingdom. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Cvs Health Corp | 30 Jun 2024 | 5,352,106 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |